The University of Chicago Header Logo

Connection

Joel R. Pekow to Liver Function Tests

Back to Details
This is a "connection" page, showing publications Joel R. Pekow has written about Liver Function Tests.
Joel R. Pekow
Connection Strength
0.039
Liver Function Tests
  1. Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease. Aliment Pharmacol Ther. 2018 Mar; 47(6):753-762.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.